Palivizumab
Generic medicine reference
Not yet clinically reviewed
This entry was migrated from the earlier Pharmapedia app bundle and has not been reviewed by a named clinician on this site. It is provided for educational reference only — verify dosage and safety information against current, authoritative sources and a qualified healthcare professional before any clinical use.
Overview
Palivizumab is a man-made antibody to respiratory syncytial (sin-SISH-ul) virus (RSV). RSV can cause serious illness in children. Palivizumab helps keep RSV cells from multiplying in the body.
Palivizumab is used to prevent serious lung disease caused by respiratory syncytial virus in premature infants, and infants born with certain lung disorders or heart disease .
Palivizumab works best in children who are 24 months old or younger at the beginning of RSV season (6 months or younger for premature infants).
Palivizumab will not treat a child who is already sick with RSV disease.
Palivizumab may also be used for other purposes not listed in this medication guide.
Indications
Palivizumab is a man-made antibody to respiratory syncytial (sin-SISH-ul) virus (RSV). RSV can cause serious illness in children. Palivizumab helps keep RSV cells from multiplying in the body.
Palivizumab is used to prevent serious lung disease caused by respiratory syncytial virus in premature infants, and infants born with certain lung disorders or heart disease .
Palivizumab works best in children who are 24 months old or younger at the beginning of RSV season (6 months or younger for premature infants).
Palivizumab will not treat a child who is already sick with RSV disease.
Palivizumab may also be used for other purposes not listed in this medication guide.
Contraindications
Palivizumab should not be given to a child who has had a severe allergic reaction to it.
Tell your doctor if your child has ever had:
a bleeding or blood clotting disorder; or low levels of platelets in the blood.
Side Effects
Get emergency medical help if your child has signs of an allergic reaction: hives, severe rash , itching ; rapid or difficult breathing; blue-colored lips, skin, or fingernails; muscle weakness, being hard to wake up; swelling of the face, lips, tongue, or throat.
Common side effects of palivizumab may include:
fever ; or rash.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Warnings
Palivizumab should not be given to a child who has had a severe allergic reaction to it.
High Risk Groups
Palivizumab should not be given to a child who has had a severe allergic reaction to it.
Adult Dosage
15 mg/kg of body weight (15 (15)) As recommended. IM —
Child Dosage
No child dosage information is recorded for this medicine yet.
Neonatal Dosage
No neonatal dosage information is recorded for this medicine yet.
Drug Interactions
Other drugs may affect palivizumab, including prescription and over-the-counter medicines, vitamins , and herbal products . Tell your doctor about all your current medicines and any medicine you start or stop using.
Storage
No storage information is recorded for this medicine yet.
Available Brands in Pakistan
No brands are recorded for this generic.